{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:20:34Z","timestamp":1792095634246,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","award":["ORI"],"award-info":[{"award-number":["ORI"]}],"id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL103931"],"award-info":[{"award-number":["R01HL103931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1616-x","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T13:42:59Z","timestamp":1528465379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Unnikrishnan M.","family":"Chandrasekharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H.","family":"Wilson Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elaine","family":"Husni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"issue":"1","key":"1616_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15\u201325.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1616_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.berh.2007.05.003","volume":"21","author":"SM Naz","year":"2007","unstructured":"Naz SM, Symmons DP. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21(5):871\u201383.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"1616_CR3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","volume":"37","author":"TM Hunter","year":"2017","unstructured":"Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 2017;37(9):1551\u20137.","journal-title":"Rheumatol Int"},{"issue":"12","key":"1616_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690\u20137.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1616_CR5","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/rheumatology\/keu224","volume":"53","author":"E Choy","year":"2014","unstructured":"Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford). 2014;53(12):2143\u201354.","journal-title":"Rheumatology (Oxford)"},{"issue":"2\u20133","key":"1616_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12026-013-8398-7","volume":"56","author":"J Amaya-Amaya","year":"2013","unstructured":"Amaya-Amaya J, Sarmiento-Monroy JC, Mantilla RD, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunol Res. 2013;56(2\u20133):267\u201386.","journal-title":"Immunol Res"},{"issue":"12","key":"1616_CR7","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID del Rincon","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44(12):2737\u201345.","journal-title":"Arthritis Rheum"},{"key":"1616_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2013.00278","volume":"4","author":"J Steppan","year":"2013","unstructured":"Steppan J, Nyhan D, Berkowitz DE. Development of novel arginase inhibitors for therapy of endothelial dysfunction. Front Immunol. 2013;4:278.","journal-title":"Front Immunol"},{"issue":"1","key":"1616_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar4450","volume":"16","author":"P Totoson","year":"2014","unstructured":"Totoson P, Maguin-Gate K, Prati C, Wendling D, Demougeot C. Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Res Ther. 2014;16(1):202.","journal-title":"Arthritis Res Ther"},{"issue":"Pt 1","key":"1616_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3360001","volume":"336","author":"G Wu","year":"1998","unstructured":"Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1\u201317.","journal-title":"Biochem J"},{"issue":"9","key":"1616_CR11","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/j.1440-1681.2007.04638.x","volume":"34","author":"W Durante","year":"2007","unstructured":"Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol. 2007;34(9):906\u201311.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"1616_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1074\/jbc.M603606200","volume":"282","author":"AJ Cardounel","year":"2007","unstructured":"Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V, Zweier JL. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem. 2007;282(2):879\u201387.","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"1616_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/bj3570593","volume":"357","author":"WK Alderton","year":"2001","unstructured":"Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(Pt 3):593\u2013615.","journal-title":"Biochem J"},{"issue":"2","key":"1616_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/1568026611313020007","volume":"13","author":"G Bouras","year":"2013","unstructured":"Bouras G, Deftereos S, Tousoulis D, Giannopoulos G, Chatzis G, Tsounis D, Cleman MW, Stefanadis C. Asymmetric dimethylarginine (ADMA): a promising biomarker for cardiovascular disease? Curr Top Med Chem. 2013;13(2):180\u2013200.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"1616_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5152\/eurjrheum.2016.15096","volume":"3","author":"T Senturk","year":"2016","unstructured":"Senturk T, Yilmaz N, Sargin G, Koseoglu K, Yenisey C. Relationship between asymmetric dimethylarginine and endothelial dysfunction in patients with rheumatoid arthritis. Eur J Rheumatol. 2016;3(3):106\u20138.","journal-title":"Eur J Rheumatol"},{"issue":"20","key":"1616_CR16","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.107.693986","volume":"116","author":"SJ Nicholls","year":"2007","unstructured":"Nicholls SJ, Wang Z, Koeth R, Levison B, DelFraino B, Dzavik V, Griffith OW, Hathaway D, Panza JA, Nissen SE, et al. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction. Circulation. 2007;116(20):2315\u201324.","journal-title":"Circulation"},{"issue":"9","key":"1616_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/ATVBAHA.109.185645","volume":"29","author":"Z Wang","year":"2009","unstructured":"Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol. 2009;29(9):1383\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1616_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","volume":"57","author":"A Meinitzer","year":"2011","unstructured":"Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, Marz W. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem. 2011;57(1):112\u201321.","journal-title":"Clin Chem"},{"issue":"11","key":"1616_CR19","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1161\/ATVBAHA.113.301219","volume":"33","author":"MO Gore","year":"2013","unstructured":"Gore MO, L\u00fcneburg N, Schwedhelm E, Ayers CR, Anderssohn M, Khera A, Atzler D, de Lemos JA, Grant PJ, McGuire DK, et al. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arterioscler Thromb Vasc Biol. 2013;33(11):2682\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"1616_CR20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","volume":"53","author":"WH Tang","year":"2009","unstructured":"Tang WH, Wang Z, Cho L, Brennan DM, Hazen SL. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol. 2009;53(22):2061\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1616_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ab.2014.03.016","volume":"455","author":"Z Wang","year":"2014","unstructured":"Wang Z, Levison BS, Hazen JE, Donahue L, Li XM, Hazen SL. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 2014;455:35\u201340.","journal-title":"Anal Biochem"},{"issue":"4","key":"1616_CR22","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1681\/ASN.2005101119","volume":"17","author":"SM Bode-Boger","year":"2006","unstructured":"Bode-Boger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, Reinecke H. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol. 2006;17(4):1128\u201334.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1616_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cardfail.2013.01.001","volume":"19","author":"WH Tang","year":"2013","unstructured":"Tang WH, Shrestha K, Wang Z, Troughton RW, Klein AL, Hazen SL. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. J Card Fail. 2013;19(2):87\u201393.","journal-title":"J Card Fail"},{"key":"1616_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fimmu.2013.00111","volume":"4","author":"W Durante","year":"2013","unstructured":"Durante W. Role of arginase in vessel wall remodeling. Front Immunol. 2013;4:111.","journal-title":"Front Immunol"},{"issue":"4","key":"1616_CR25","doi-asserted-by":"publisher","first-page":"e000992","DOI":"10.1161\/JAHA.112.000992","volume":"1","author":"XF Ming","year":"2012","unstructured":"Ming XF, Rajapakse AG, Yepuri G, Xiong Y, Carvas JM, Ruffieux J, Scerri I, Wu Z, Popp K, Li J, et al. Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species, contributing to insulin resistance and atherogenesis. J Am Heart Assoc. 2012;1(4):e000992.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1616_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","volume":"158","author":"M Munder","year":"2009","unstructured":"Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol. 2009;158(3):638\u201351.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1616_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/cvr\/cvt036","volume":"98","author":"J Pernow","year":"2013","unstructured":"Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res. 2013;98(3):334\u201343.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1616_CR28","first-page":"1138","volume":"37","author":"EB Spector","year":"1985","unstructured":"Spector EB, Rice SC, Kern RM, Hendrickson R, Cederbaum SD. Comparison of arginase activity in red blood cells of lower mammals, primates, and man: evolution to high activity in primates. Am J Hum Genet. 1985;37(6):1138\u201345.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1616_CR29","first-page":"358","volume":"17","author":"LW Huang","year":"2001","unstructured":"Huang LW, Chang KL, Chen CJ, Liu HW. Arginase levels are increased in patients with rheumatoid arthritis. Kaohsiung J Med Sci. 2001;17(7):358\u201363.","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"1616_CR30","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar3860","volume":"14","author":"C Prati","year":"2012","unstructured":"Prati C, Berthelot A, Kantelip B, Wendling D, Demougeot C. Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis. Arthritis Res Ther. 2012;14(3):R130.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1616_CR31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/rheumatology\/kep082","volume":"48","author":"M Turiel","year":"2009","unstructured":"Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, Longhi M, Sitia S, Bianchi M, Ferrario P, et al. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. Rheumatology (Oxford). 2009;48(7):834\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1616_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/art.22424","volume":"56","author":"A Surdacki","year":"2007","unstructured":"Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, Dubiel JS, Pryjma J, Bode-Boger SM. Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2007;56(3):809\u201319.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1616_CR33","doi-asserted-by":"publisher","first-page":"12315","DOI":"10.3390\/ijms131012315","volume":"13","author":"T Dimitroulas","year":"2012","unstructured":"Dimitroulas T, Sandoo A, Kitas GD. Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. Int J Mol Sci. 2012;13(10):12315\u201335.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1616_CR34","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/keu349","volume":"54","author":"A Sandoo","year":"2015","unstructured":"Sandoo A, Dimitroulas T, Hodson J, Smith JP, Douglas KM, Kitas GD. Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study. Rheumatology (Oxford). 2015;54(7):1145\u201352.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1616_CR35","first-page":"388","volume":"30","author":"A Sandoo","year":"2012","unstructured":"Sandoo A, Dimitroulas T, Veldhuijzen van Zanten JJ, Smith JP, Metsios GS, Nightingale P, Stavropoulos-Kalinoglou A, Kitas GD: Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis. Clin Exp Rheumatol 2012;30(3):388\u2013396.","journal-title":"Clin Exp Rheumatol"},{"issue":"1 Suppl","key":"1616_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0300060515593255","volume":"44","author":"GL Erre","year":"2016","unstructured":"Erre GL, Piras A, Mura S, Mundula N, Piras M, Taras L, Longu MG, Saba PS, Ganau A, Carru C, et al. Asymmetric dimethylarginine and arterial stiffness in patients with rheumatoid arthritis: a case-control study. J Int Med Res. 2016;44(1 Suppl):76\u201380.","journal-title":"J Int Med Res"},{"issue":"2","key":"1616_CR37","doi-asserted-by":"publisher","first-page":"e002762","DOI":"10.1161\/JAHA.115.002762","volume":"5","author":"KM M\u00e4ki-Pet\u00e4j\u00e4","year":"2016","unstructured":"M\u00e4ki-Pet\u00e4j\u00e4 KM, Day L, Cheriyan J, Hall FC, \u00d6st\u00f6r AJ, Shenker N, Wilkinson IB. Tetrahydrobiopterin supplementation improves endothelial function but does not alter aortic stiffness in patients with rheumatoid arthritis. J Am Heart Assoc. 2016;5(2):e002762.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1616_CR38","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00726-015-1953-x","volume":"47","author":"T Dimitroulas","year":"2015","unstructured":"Dimitroulas T, Hodson J, Sandoo A, Smith J, Kitas GD. Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores. Amino Acids. 2015;47(9):1995\u20132004.","journal-title":"Amino Acids"},{"issue":"1","key":"1616_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13075-017-1232-1","volume":"19","author":"T Dimitroulas","year":"2017","unstructured":"Dimitroulas T, Hodson J, Sandoo A, Smith J, Kitas GD. Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. Arthritis Res Ther. 2017;19(1):32.","journal-title":"Arthritis Res Ther"},{"key":"1616_CR40","doi-asserted-by":"publisher","first-page":"796562","DOI":"10.1155\/2015\/796562","volume":"2015","author":"T Dimitroulas","year":"2015","unstructured":"Dimitroulas T, Hodson J, Sandoo A, Smith JP, Douglas KM, Kitas GD. Symmetric dimethylarginine is not associated with cumulative inflammatory load or classical cardiovascular risk factors in rheumatoid arthritis: a 6-year follow-up study. Mediat Inflamm. 2015;2015:796562.","journal-title":"Mediat Inflamm"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1616-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:56:27Z","timestamp":1589550987000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1616-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1616-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"18 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional review board (IRB) of the Cleveland Clinic approved the consent form that the participants signed. All participants gave written informed consent according to the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"123"}}